New developments in aminoglycoside therapy and ototoxicity

After almost seven decades in clinical use, aminoglycoside antibiotics still remain indispensible drugs for acute infections and specific indications such as tuberculosis or the containment of pseudomonas bacteria in patients with cystic fibrosis. The review will describe the pathology and pathophysiology of aminoglycoside-induced auditory and vestibular toxicity in humans and experimental animals and explore contemporary views of the mechanisms of cell death. It will also outline the current state of protective therapy and recent advances in the development of aminoglycoside derivatives with low toxicity profiles for antimicrobial treatment and for stop-codon suppression in the attenuation of genetic disorders.

[1]  Mordechai Shohat,et al.  Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafness , 1993, Nature Genetics.

[2]  J. Frangos,et al.  Involvement of ras activation in toxic hair cell damage of the mammalian cochlea , 2003, Neuroscience.

[3]  J. Schacht,et al.  EFFECT OF NEOMYCIN ON PHOSPHOINOSITIDE LABELLING AND CALCIUM BINDING IN GUINEA‐PIG INNER EAR TISSUES IN VIVO AND IN VITRO 1 , 1976, Journal of neurochemistry.

[4]  Uwe Fass,et al.  Readthrough of dystrophin stop codon mutations induced by aminoglycosides , 2004, Annals of neurology.

[5]  D. Paterson,et al.  Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity , 2011, Internal medicine journal.

[6]  Shyam Sundar,et al.  Injectable paromomycin for Visceral leishmaniasis in India. , 2007, The New England journal of medicine.

[7]  J. Schacht,et al.  Rac/Rho pathway regulates actin depolymerization induced by aminoglycoside antibiotics , 2006, Journal of neuroscience research.

[8]  E. Rubel,et al.  Reactive oxygen species in chick hair cells after gentamicin exposure in vitro , 1997, Hearing Research.

[9]  J. Wersäll,et al.  Ototoxicity of gentamicin. , 1969, The Journal of infectious diseases.

[10]  J. Veldman,et al.  Ultrastructural localization of gentamicin in the cochlea , 1990, Hearing Research.

[11]  G. Koren,et al.  Is gentamicin ototoxic to the fetus? , 2007, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[12]  G. Zhanel,et al.  Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents. , 2010, Bioorganic & medicinal chemistry letters.

[13]  E. Böttger,et al.  Structural basis for selectivity and toxicity of ribosomal antibiotics , 2001, EMBO reports.

[14]  J. Schacht,et al.  Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo , 2006, Journal of neurochemistry.

[15]  T. Sirimanna,et al.  Aminoglycoside antibiotics cochleotoxicity in paediatric cystic fibrosis (CF) patients: A study using extended high-frequency audiometry and distortion product otoacoustic emissions , 2011, International journal of audiology.

[16]  J. Wilhelm,et al.  Fidelity of the eukaryotic codon-anticodon interaction: interference by aminoglycoside antibiotics. , 1984, Biochemistry.

[17]  W. Feldman,et al.  Streptomycin in Treatment of Clinical Tuberculosis: a Preliminary Report. , 1945 .

[18]  J. Schacht,et al.  Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo , 1996, Hearing Research.

[19]  M. Goodarzi,et al.  Can aspirin protect or at least attenuate gentamicin ototoxicity in humans? , 2009, Saudi medical journal.

[20]  M. Nagura,et al.  Ultrastructural localization of megalin in the rat cochlear duct , 1999, Hearing Research.

[21]  J. Blanchard,et al.  Molecular insights into aminoglycoside action and resistance. , 2005, Chemical reviews.

[22]  A. Uziel,et al.  Comparative ototoxicity of four aminoglycosidic antibiotics during the critical period of cochlear development in the rat. A functional and structural study. , 1983, Acta oto-laryngologica. Supplementum.

[23]  J. Schacht,et al.  Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant , 2000, Hearing Research.

[24]  C. Kros,et al.  The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano 
‐electrical transducer channels , 2005, The Journal of physiology.

[25]  E. Hawkins.  Ototoxic mechanisms. A working hypothesis. , 1973, Audiology : official organ of the International Society of Audiology.

[26]  Y. Raphael,et al.  Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. , 1999, Human gene therapy.

[27]  J. Schacht,et al.  NF‐κB pathway protects cochlear hair cells from aminoglycoside‐induced ototoxicity , 2005, Journal of neuroscience research.

[28]  G. Miller,et al.  Combating evolution with intelligent design: the neoglycoside ACHN-490. , 2010, Current opinion in microbiology.

[29]  J. Schacht,et al.  Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. , 2009, Journal of medicinal chemistry.

[30]  J. Virkkala,et al.  Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death , 2002, Hearing Research.

[31]  Eric W.F.W. Alton,et al.  Cystic fibrosis , 2007, BMJ : British Medical Journal.

[32]  S. Kilty.  Canadian guidelines for rhinosinusitis: practical tools for the busy clinician , 2012, BMC Ear, Nose and Throat Disorders.

[33]  J. Aran,et al.  Cellular and subcellular localization of tritiated gentamicin in the guinea pig cochlea following combined treatment with ethacrynic acid , 1992, Hearing Research.

[34]  S. Lerner,et al.  Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. , 1986, The American journal of medicine.

[35]  D. Lim,et al.  Effects of noise and ototoxic drugs at the cellular level in the cochlea: a review. , 1986, American journal of otolaryngology.

[36]  S. Moestrup,et al.  Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. , 1995, The Journal of clinical investigation.

[37]  Eitan Kerem,et al.  Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial , 2008, The Lancet.

[38]  A. Ryan,et al.  A PI3K Pathway Mediates Hair Cell Survival and Opposes Gentamicin Toxicity in Neonatal Rat Organ of Corti , 2006, Journal of the Association for Research in Otolaryngology.

[39]  D. Oliver,et al.  Aminoglycosides Inhibit KCNQ4 Channels in Cochlear Outer Hair Cells via Depletion of Phosphatidylinositol(4,5)bisphosphate , 2011, Molecular Pharmacology.

[40]  Joe C. Adams,et al.  Distribution of Gentamicin in the Guinea Pig Inner Ear after Local or Systemic Application , 2003, Journal of the Association for Research in Otolaryngology.

[41]  R. Romand,et al.  Ototoxicity of kanamycin in developing rats: Relationship with the onset of the auditory function , 1980, Hearing Research.

[42]  K. Fischbeck,et al.  Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations , 2001, Annals of neurology.

[43]  S. Lerner,et al.  Cochlear neural degeneration without hair cell loss in two patients with aminoglycoside ototoxicity. , 1987, The Journal of infectious diseases.

[44]  Alimuddin Zumla,et al.  Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. , 2010, The Lancet. Infectious diseases.

[45]  Saumil N. Merchant,et al.  Temporal Bone Studies of the Human Peripheral Vestibular System , 2000, The Annals of otology, rhinology & laryngology. Supplement.

[46]  G. Ramesh,et al.  Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. , 2004, Kidney international.

[47]  R. Salvi,et al.  Lysosomal targeting and accumulation of aminoglycoside antibiotics in sensory hair cells , 1997, Brain Research.

[48]  F. de Ribaupierre,et al.  A Peptide Inhibitor of C-jun N-terminal Kinase Protects against Both Aminoglycoside and Acoustic Trauma-induced Auditory Hair Cell Death and Hearing Loss , 2022 .

[49]  Thakur Cp.  Tetany in kala azar patients treated with paromomycin. , 2008 .

[50]  F. Erdoğan,et al.  Comparative vestibulotoxicity of different aminoglycosides in the Guinea pigs. , 2003, Yonsei medical journal.

[51]  D. W. Morgan,et al.  Occurrence and Risk of Cochleotoxicity in Cystic Fibrosis Patients Receiving Repeated High-Dose Aminoglycoside Therapy , 2001, Antimicrobial Agents and Chemotherapy.

[52]  A. Eshraghi,et al.  Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity , 2007, Hearing Research.

[53]  James B. Hill,et al.  Ampicillin Resistance and Outcome Differences in Acute Antepartum Pyelonephritis , 2008, Infectious diseases in obstetrics and gynecology.

[54]  J. Henry,et al.  Early detection of ototoxicity using high-frequency, tone-burst-evoked auditory brainstem responses. , 1992, Journal of the American Academy of Audiology.

[55]  J. Schacht,et al.  Formation of reactive oxygen species following bioactivation of gentamicin. , 1999, Free radical biology & medicine.

[56]  K. Kawamoto,et al.  Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  M. Fridman,et al.  Branched aminoglycosides: biochemical studies and antibacterial activity of neomycin B derivatives. , 2005, Bioorganic & medicinal chemistry.

[58]  A. Caughey,et al.  Daily Compared With 8-Hour Gentamicin for the Treatment of Intrapartum Chorioamnionitis: A Randomized Controlled Trial , 2010, Obstetrics and gynecology.

[59]  D. Brough,et al.  Bcl-2 Gene Therapy Prevents Aminoglycoside-Induced Degeneration of Auditory and Vestibular Hair Cells , 2009, Audiology and Neurotology.

[60]  J. Schacht,et al.  Aminoglycoside‐induced histone deacetylation and hair cell death in the mouse cochlea , 2009, Journal of neurochemistry.

[61]  B. Ryals,et al.  Morphological evidence of ototoxicity of the iron chelator deferoxamine , 1997, Hearing Research.

[62]  N. Weiner,et al.  Ototoxicity of aminoglycosides correlated with their action on monomolecular films of polyphosphoinositides. , 1980, Biochemical pharmacology.

[63]  J. C. de Groot,et al.  Human cochlear pathology in aminoglycoside ototoxicity--a review. , 1987, Acta oto-laryngologica. Supplementum.

[64]  A. Forge,et al.  Caspase-independent pathways of hair cell death induced by kanamycin in vivo , 2006, Cell Death and Differentiation.

[65]  Katalin Susztak,et al.  Fine tuning gene expression: the epigenome. , 2010, Seminars in nephrology.

[66]  Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. , 2007, Anti-cancer agents in medicinal chemistry.

[67]  D. Butterfield,et al.  Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants , 1996, Hearing Research.

[68]  C. Kies,et al.  Comparative value of L-, and D-methionine supplementation of an oat-based diet for humans. , 1975, The Journal of nutrition.

[69]  K. Steel,et al.  Myosin VIIA Is Required for Aminoglycoside Accumulation in Cochlear Hair Cells , 1997, The Journal of Neuroscience.

[70]  A. Forge,et al.  Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals , 2001, Hearing Research.

[71]  Joseph I. Ambrus,et al.  Dual action-based approaches to antibacterial agents. , 2007, Current medicinal chemistry.

[72]  L. Rybak,et al.  Ototoxicity: therapeutic opportunities. , 2005, Drug discovery today.

[73]  K. Poole,et al.  Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates , 2003, Antimicrobial Agents and Chemotherapy.

[74]  W C Stebbins,et al.  LXXXVII Ototoxic Hearing Loss and Cochlear Pathology in the Monkey , 1969, The Annals of otology, rhinology, and laryngology.

[75]  B. Kerem,et al.  Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. , 2003, The New England journal of medicine.

[76]  D. Raible,et al.  Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss. , 2010, Drug discovery today.

[77]  J. Nedzelski,et al.  Intratympanic Gentamicin for the Treatment of Unilateral Meniere's Disease , 2000, The Laryngoscope.

[78]  J. Virkkala,et al.  Rescue of Hearing, Auditory Hair Cells, and Neurons by CEP-1347/KT7515, an Inhibitor of c-Jun N-Terminal Kinase Activation , 2000, The Journal of Neuroscience.

[79]  J. Schacht,et al.  Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity. , 1998, Free radical biology & medicine.

[80]  J. Schacht,et al.  Aspirin to prevent gentamicin-induced hearing loss. , 2006, The New England journal of medicine.

[81]  A. Baccioglu,et al.  Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis. , 2006, Respiratory medicine.

[82]  R. Kaufman,et al.  Correction of genetic disease by making sense from nonsense. , 1999, The Journal of clinical investigation.

[83]  F. Lee,et al.  Hsp70 inhibits aminoglycoside-induced hearing loss and cochlear hair cell death , 2009, Cell Stress and Chaperones.

[84]  A. Guilhaume,et al.  Ototoxicité de la Kanamycine au jour le jour. Etude expérimentale en microscopie électronique , 1974 .

[85]  K. Horiguchi,et al.  Identification of sodium salicylate as an hsp inducer using a simple screening system for stress response modulators in mammalian cells. , 2003, European journal of biochemistry.

[86]  C. Destache,et al.  Individualized Pharmacokinetic Monitoring Results in Less Aminoglycoside‐Associated Nephrotoxicity and Fewer Associated Costs , 2001, Pharmacotherapy.

[87]  Z. Dotan,et al.  The Effect of Vecuronium Is Enhanced by a Large Rather than a Modest Dose of Gentamicin as Compared with No Preoperative Gentamicin , 2003, Anesthesia and analgesia.

[88]  J. Burke,et al.  Suppression of a nonsense mutation in mammalian cells in vivo by the aminoglycoside antibiotics G-418 and paromomycin. , 1985, Nucleic acids research.

[89]  J. Clancy,et al.  Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. , 2001, American journal of respiratory and critical care medicine.

[90]  A. Ryan,et al.  Generation of highly-reactive oxygen species is closely related to hair cell damage in rat organ of corti treated with gentamicin , 2009, Neuroscience.

[91]  Yinshi Guo,et al.  Aminoglycoside Ototoxicity in Nicaraguan children: Patient risk Factors and Mitochondrial DNA Results , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[92]  F. Ratjen,et al.  Cystic fibrosis , 2003, The Lancet.

[93]  R. Moore,et al.  Risk factors for the development of auditory toxicity in patients receiving aminoglycosides. , 1984, The Journal of infectious diseases.

[94]  S. Haydel.  Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery , 2010, Pharmaceuticals.

[95]  P. Steyger,et al.  TRPV1 regulators mediate gentamicin penetration of cultured kidney cells , 2005, Hearing Research.

[96]  J. Schacht,et al.  Does vitamin E prevent gentamicin-induced ototoxicity? , 2007, Georgian medical news.

[97]  K. Kawamoto,et al.  Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague–Dawley rat , 2001, Hearing Research.

[98]  Eric M. Priuska,et al.  Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. , 1995, Biochemical pharmacology.

[99]  M. Giala,et al.  Interaction of aminoglycoside antibiotics and calcium channel blockers at the neuromuscular junctions. , 1988, Methods and findings in experimental and clinical pharmacology.

[100]  A. Corrado,et al.  The curariform action of streptomycin. , 1957, The Journal of pharmacology and experimental therapeutics.

[101]  J. Schacht,et al.  Salicylate attenuates gentamicin-induced ototoxicity. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[102]  H. Sweeney,et al.  Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. , 1999, The Journal of clinical investigation.

[103]  D. E. Smith,et al.  Characteristics of gentamicin uptake in the isolated crista ampullaris of the inner ear of the guinea pig. , 1987, Biochemical pharmacology.

[104]  J. Mendell,et al.  Gentamicin‐induced readthrough of stop codons in duchenne muscular dystrophy , 2010, Annals of neurology.

[105]  T. Barto,et al.  Treatment of Pulmonary Exacerbations in Adult Cystic Fibrosis Patients: A Review , 2010, Hospital practice.

[106]  D. Sleat,et al.  Aminoglycoside-mediated suppression of nonsense mutations in late infantile neuronal ceroid lipofuscinosis. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[107]  J. Heller.  Effect of some simple manoeuvres on the course of acute renal failure after gentamycin treatment in rats , 2005, International Urology and Nephrology.

[108]  D. S. Pilch,et al.  Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity. , 2006, Journal of the American Chemical Society.

[109]  T. Baasov,et al.  Aminoglycosides : Redesign Strategies for Improved Antibiotics and Compounds for Treatment of Human Genetic Diseases , 2010 .

[110]  B. Frederiksen,et al.  Improved survival in the Danish center‐treated cystic fibrosis patients: Results of aggressive treatment , 1996, Pediatric pulmonology.

[111]  R. Altena.  Hearing loss and nephrotoxicity treatment in patients with in long-term aminoglycoside tuberculosis , 2002 .

[112]  E. Eviatar,et al.  Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine. , 2007, Kidney international.

[113]  L. Schieve,et al.  Urinary tract infection during pregnancy: its association with maternal morbidity and perinatal outcome. , 1994, American journal of public health.

[114]  Melissa A. Miller,et al.  Management of Aminoglycosides in the Intensive Care Unit , 2010, Journal of intensive care medicine.